abstract |
FIELD: medicine. ^ SUBSTANCE: invention relates to pharmaceutical composition, which contains ZD6474 or its pharmaceutically acceptable salt, fragile thinner and second thinner, which is practically insoluble and possesses compression plasticity. Fragile thinner represents calcium hydrophosphate, and second thinner, which is practically insoluble and possesses compression plasticity, represents microcrystalline cellulose. ^ EFFECT: good bioavailability for active substance. ^ 5 cl, 7 tbl, 5 ex, 2 dwg |